Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Lugol's Solution Concentration for Esophageal Chromoendoscopy
NCT03180944Phase 2Completed
- Sponsor
- Shandong University
- Start
- Sep 2017
- Primary completion
- Nov 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Lugol's solution in Esophageal Squamous Cell Carcinoma (ESCC) (5 arms), sponsored by Shandong University. Primary endpoint: Image Quality. Started Sep 2017; status: completed.
02
Drugs
Lugol's solution
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT03180944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03180944.